IQX Limited (NSX:IQX) FDA Breakthrough Devices Designation - ABN Newswire (@ABN_Newswire)
IQX Limited (NSX:IQX) has filed an application with the U.S Food and Drug Administration (FDA) for Breakthrough Device Designation.
Stay updated with breaking news from Devices Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
IQX Limited (NSX:IQX) has filed an application with the U.S Food and Drug Administration (FDA) for Breakthrough Device Designation.
/PRNewswire/ -- Life Science Biosensor Diagnostics Pty Ltd (LSBD), a life sciences and medical technology company and subsidiary of The iQ Group Global,...
SYDNEY, Dec. 15, 2021 /PRNewswire/ — Life Science Biosensor Diagnostics Pty Ltd (LSBD), a life sciences and medical technology company...
NEW YORK, Dec. 13, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for...
Lungs among most common site for metastatic tumors